Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

202

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

June 30, 2029

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Fulvestrant plus AI plus ribociclib

Fulvestrant + AI + ribociclib +/- GnRH agonist

DRUG

AI plus ribociclib

AI + ribociclib +/- GnRH agonist

Trial Locations (2)

RECRUITING

Korea university Guro hospital, Seoul

RECRUITING

St Mary Hospital, Seoul

All Listed Sponsors

lead

Korea University Guro Hospital

OTHER